Landscape Capital Management L.L.C. Sells 19,009 Shares of The Cooper Companies, Inc. $COO

Landscape Capital Management L.L.C. reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 33.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 38,160 shares of the medical device company’s stock after selling 19,009 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Cooper Companies were worth $3,128,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. New York Life Investment Management LLC grew its stake in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares during the period. Root Financial Partners LLC grew its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. Allworth Financial LP grew its stake in shares of Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares during the period. Mesirow Financial Investment Management Inc. grew its stake in shares of Cooper Companies by 1.3% in the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after acquiring an additional 175 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after acquiring an additional 185 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $67.88 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a market capitalization of $13.24 billion, a P/E ratio of 57.53, a P/E/G ratio of 1.78 and a beta of 0.88. The firm’s 50 day simple moving average is $64.79 and its two-hundred day simple moving average is $74.34.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the firm earned $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on COO. Barclays lifted their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Wall Street Zen downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a report on Wednesday, May 27th. Finally, Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $82.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.